Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)

China flag China · Delayed Price · Currency is CNY
56.80
-1.80 (-3.07%)
At close: Feb 2, 2026
69.15%
Market Cap8.61B +76.6%
Revenue (ttm)829.92M -26.0%
Net Income204.44K -99.9%
EPS0.00 -99.9%
Shares Out140.98M
PE Ratio42,112.39
Forward PEn/a
Dividend0.32 (0.56%)
Ex-Dividend Daten/a
Volume1,104,075
Average Volume2,405,737
Open58.22
Previous Close58.60
Day's Range56.61 - 58.79
52-Week Range29.10 - 72.00
Betan/a
RSI47.88
Earnings DateApr 30, 2026

About SHA:688710

Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. The company offers screening and discovery, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines. The company was founded in 2010 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2010
Employees 1,092
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688710
Full Company Profile

Financial Performance

In 2024, SHA:688710's revenue was 1.14 billion, an increase of 9.94% compared to the previous year's 1.04 billion. Earnings were 147.78 million, a decrease of -24.00%.

Financial Statements